文献
J-GLOBAL ID:201802225805532758
整理番号:18A1423748
後天性免疫血栓性血小板減少性紫斑病の治療のためのルーチン使用における病原体不活性化および検疫血漿の有効性および安全性の特性化【JST・京大機械翻訳】
Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura
著者 (15件):
Herbrecht R.
(Centre de Competence des Microangiopathies d’Alsace, Strasbourg, France)
,
Herbrecht R.
(Hopitaux Universitaires de Strasbourg, Strasbourg, France)
,
Ojeda-Uribe M.
(Centre de Competence des Microangiopathies d’Alsace, Strasbourg, France)
,
Ojeda-Uribe M.
(CH Emile Muller, Mulhouse, France)
,
Kientz D.
(EFS Alsace, Strasbourg, France)
,
Fohrer C.
(Centre de Competence des Microangiopathies d’Alsace, Strasbourg, France)
,
Fohrer C.
(Hopitaux Universitaires de Strasbourg, Strasbourg, France)
,
Bohbot A.
(Hopitaux Universitaires de Strasbourg, Strasbourg, France)
,
Hinschberger O.
(CH Emile Muller, Mulhouse, France)
,
Liu K.-L.
(CH Emile Muller, Mulhouse, France)
,
Remy E.
(EFS Alsace, Strasbourg, France)
,
Ernst C.
(Cerus Corporation, Concord, CA, USA)
,
Lin J.-S.
(Cerus Corporation, Concord, CA, USA)
,
Corash L.
(Cerus Corporation, Concord, CA, USA)
,
Cazenave J. P.
(Association ARMESA, Strasbourg, France)
資料名:
Vox Sanguinis
(Vox Sanguinis)
巻:
113
号:
5
ページ:
459-467
発行年:
2018年
JST資料番号:
C0866B
ISSN:
0042-9007
CODEN:
VOSAAD
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)